Treatment alternatives for chronic hepatitis B virus infection: a cost-effectiveness analysis. [electronic resource]
Producer: 20050526Description: 821-31 p. digitalISSN:- 1539-3704
- Adenine -- analogs & derivatives
- Antiviral Agents -- economics
- Cost-Benefit Analysis
- Decision Support Techniques
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- immunology
- Hepatitis B, Chronic -- drug therapy
- Humans
- Interferon alpha-2
- Interferon-alpha -- economics
- Lamivudine -- economics
- Liver -- enzymology
- Markov Chains
- Organophosphonates -- economics
- Recombinant Proteins
- Salvage Therapy
- Sensitivity and Specificity
- Transaminases -- blood
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.